Mode
Text Size
Log in / Sign up

Mirikizumab

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of Mirikizumab

12 trials tracked of Mirikizumab: 4 in phase 3 or 4 and 4 with published results. The most-cited published study has 28 citations.

12Trials tracked
4Phase 3 & 4
0Recruiting
4With published results
Phase distribution
Phase 3 4 Phase 2 4 Phase 1 4
  1. Phase 3 A Study to Assess if Mirikizumab is Effective and Safe Compared to Secukinumab and Placebo in Moderate to Severe Plaque Psoriasis (OASIS-2) Completed · 28 cited
  2. Phase 3 An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1) Completed · 23 cited
  3. Phase 3 A Study to Evaluate the Efficacy and Safety of Mirikizumab (LY3074828) in Participants With Moderate-to-Severe Plaque Psoriasis Completed · 11 cited
  4. Phase 3 A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease Completed · 4 cited
  5. Phase 2 A Study of Mirikizumab (LY3074828) in Participants With Active Crohn's Disease Completed
  6. Phase 2 A Study of Mirikizumab (LY3074828) in Children and Teenagers With Ulcerative Colitis (UC) Completed
Show 6 more trials
  1. Phase 2 A Study of Mirikizumab (LY3074828) in Participants With Moderate to Severe Plaque Psoriasis Completed
  2. Phase 2 A Study of Mirikizumab (LY3074828) in Participants With Moderate to Severe Ulcerative Colitis Completed
  3. Phase 1 A Bioequivalence Study of Mirikizumab (LY3074828) Solution in Healthy Participants Completed
  4. Phase 1 A Study to Compare Two Different Formulations of Mirikizumab in Healthy Participants Completed
  5. Phase 1 A Study of Mirikizumab in Participants With Plaque Psoriasis Completed
  6. Phase 1 A Bioequivalence Study of Mirikizumab (LY3074828) in Healthy Participants Completed

Showing the 12 most-cited and recently-updated of 12 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this medication. Check back soon.